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Abstract
The ability of cells to sense and respond appropriately to changing environmental conditions is
often mediated by signal transduction pathways that employ mitogen-activated protein kinases
(MAPKs). In the yeast Saccharomyces cerevisiae, the high osmolarity glycerol (HOG) and the
filamentous growth (FG) pathways are activated following hyperosmotic stress and nutrient
deprivation, respectively. Whereas the HOG pathway requires the MAPK Hog1, the FG pathway
employs the MAPK Kss1. We conducted a comprehensive screen of nearly 5,000 gene deletion
strains for mutants that exhibit inappropriate cross-talk between the HOG and FG pathways. We
identified two novel mutants, mnn10Δ and mnn11Δ, that allow activation of Kss1 under
conditions that normally stimulate Hog1. MNN10 and MNN11 encode mannosyltransferases that
are part of the N-glycosylation machinery within the Golgi apparatus; deletion of either gene
results in N-glycosylated proteins that have shorter mannan chains. Deletion of the cell surface
mucin Msb2 suppressed the mnn11Δ phenotype, while mutation of a single glycosylation site
within Msb2 was sufficient to confer inappropriate activation of Kss1 by salt stress. These
findings reveal new components of the N-glycosylation machinery needed to ensure MAPK
signaling fidelity.
The ability of cells to sense and respond to changes in their environment is fundamental to
cell survival. The mitogen-activated protein kinases (MAPKs) are commonly employed to
transduce extracellular signals and to evoke specific intracellular responses (1). MAPKs are
part of an evolutionarily-conserved three-tiered signaling cascade consisting of the MAPK, a
MAPK kinase (MAPKK), and a MAPKK kinase (MAPKKK). In mammalian cells, MAPKs
mediate responses to a variety of stimuli such as hormones, stresses, and cytokines, which
promote cell proliferation, differentiation, and inflammation. Clearly, the signals that initiate
these events must be transmitted in a tightly regulated manner. The complexities of these
pathways, however, have hindered our understanding of MAPK regulation.
MAPK pathways are also present in the unicellular eukaryote Saccharomyces cerevisiae
(hereafter, yeast). Due to its relative simplicity and the ease of genetic manipulation, yeast
has emerged as an excellent model system for investigating the MAPK pathway and points
of regulation. Indeed, studies in yeast have revealed key pathway components and improved
our understanding of how these components are regulated (2).
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Among the MAPK pathways in yeast, the most well-studied are the pheromone response
pathway, the high osmolarity glycerol (HOG) pathway, and the filamentous growth (FG)
pathway (detailed in Figure 1). Each of these pathways is activated by a different stimulus
and employs a distinct MAPK. In the HOG pathway, high osmotic stress activates the three-
component kinase cascade: Ste11 (or Ssk2/Ssk22), Pbs2, and the MAPK Hog1. Activated
Hog1 promotes events leading to stress adaptation, including cell cycle arrest and increased
glycerol production to restore osmotic balance (2–5). The filamentous growth pathway
responds to nutrient deprivation by activating Ste11, Ste7, and the MAPK Kss1, which
promotes increased cell-cell adhesion, increased cell-substratum adhesion, and an increased
ability of cells to penetrate the substratum. These phenotypes may comprise a foraging
response to allow non-motile cells to grow into their surroundings in a search for additional
nutrients (2, 6, 7). In haploid yeast cells, this response is termed “invasive growth” (8),
while in diploids it is termed “pseudohyphal growth” (9, 10). Finally, in the mating response
pathway, a pheromone signal leads to the activation of Ste11, Ste7, and the MAPK Fus3,
which initiates a series of changes that include cell cycle arrest, cytoskeletal rearrangements,
and new gene transcription that lead to cell fusion and mating (2, 11–13).
The HOG, FG, and mating pathways share several components (Figure 1) and yet they
exhibit remarkable signal fidelity when stimulated individually. The prevalence of shared
components raises the question of how pathway fidelity is regulated and maintained so that a
signal transmitted though one pathway does not cross-activate another pathway. Prior work
has revealed dynamic mechanisms that help these pathways function in a mutually exclusive
manner. For instance, when exposed to a hyperosmotic environment, cells lacking Pbs2 or
Hog1 exhibit sustained activation of Kss1 and undergo filamentous growth (14–17). This
finding suggests that activated Hog1 normally phosphorylates proteins that serve to limit
activation of the competing FG pathway and does so in a dynamically-regulated (stimulus-
dependent) manner. Hog1 was later shown to repress Kss1 in part through phosphorylation
of the MAPKKK adaptor Ste50 (18, 19).
In addition to dynamic feedback mechanisms, pathway fidelity can also be maintained by
static mechanisms involving scaffold proteins. The Ste11 adaptor protein Ste50 behaves as a
dynamic integrator of multiple signals (18–20). The kinase scaffold protein Ste5 was
originally thought to serve as a signal insulator (2, 21), although current evidence indicates
that it is also a dynamic regulator of Fus3 activity (22, 23). To identify new components that
regulate cross-pathway signaling, we screened for mutants that display inappropriate MAPK
responses in a high-salt environment. By this approach, we identified gene deletion mutants
that exhibit hyperactivation of Kss1 in response to osmotic stress stimulation. These genes,
MNN10 and MNN11, each encode a subunit of the Golgi mannosyltransferase complex
needed for proper N-glycosylation of proteins (24). Deletion of a known glycoprotein
(Msb2), or potential Msb2 binding partners at the plasma membrane (Sho1, Opy2), or
downstream effectors of Msb2 (Ste20, Ste50, Ste11, Ste7) was sufficient to suppress
hyperactivation of Kss1. Finally, mutation of a single putative N-glycosylation site within a
single shared component, Msb2, led to inappropriate activation of Kss1, in the manner of
mnn10Δ and mnn11Δ. We propose that N-glycosylation of Msb2 is needed for insulation of
pathway signaling components and to promote MAPK signaling fidelity.
EXPERIMENTAL PROCEDURES
Strains and growth conditions
Standard procedures for the growth, maintenance and transformation of yeast and bacteria
and for the manipulation of DNA were used throughout. Yeast Saccharomyces cerevisiae
strains used in this study were BY4741 (MATa leu2 met15Δ his3-1 ura3Δ). Strains from
the Yeast Knock-out (YKO) gene deletion library (25) were used for the initial genetic
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screen (Supporting Information, Table S1). Aside from Table S1, all of our analysis was
done using mutant strains that had been reconstructed by PCR amplification of YKO
genomic DNA and homologous recombination in BY4741. All double mutants were
constructed by PCR amplification of LEU2, URA3, or HIS3 cassettes and homologous
recombination in mnn11Δ. The mnn10Δ mnn11Δ double mutant is reported to be viable
and to exhibit the same phenotype as the individual mutations (26). However, we have not
been able to sporulate the heterozygous diploid in our strain background, and so we were not
able to characterize the double mutant or to verify the earlier findings.
Cells were routinely grown at 30°C in synthetic complete dextrose (SCD) liquid medium
(yeast nitrogen base w/o amino acids, ammonium sulfate, adenine, amino acids, dextrose) or
in selective medium where needed for plasmid maintenance.
Plasmid construction
pRS313-MNN11, pRS316-SNF3, pRS315-SHO1, pRS313-RGT2, and pRS316-STE50 were
constructed by PCR amplification from BY4741 genomic DNA, restriction digestion, and
ligation into the indicated pRS-series vectors (ATCC). pRS316-MSB2 was constructed by
PCR amplification of MSB2 from BY4741 genomic DNA and gap repair with pRS316 in
yeast. Human influenza hemagglutinin (HA) epitope tags were introduced by site-directed
mutagenesis to construct pRS316-SNF3-HA, pRS313-RGT2-HA, and pRS316-MSB2-HA.
The FLAG epitope tag was introduced by site-directed mutagenesis to construct pRS315-
SHO1-FLAG. pRS316-ste505A was constructed as described previously (18, 19). All N-
glycosylation site mutations were constructed with the QuikChange site-directed
mutagenesis kit (Stratagene), according to the manufacturer’s directions. Mutagenic
oligonucleotides (plus complementary strand, not shown) were as follows: msb2N30A: 5′-
CCT TCG ACT TTA TAT TCG GCG CTG GAA CGC AAC AAG CTC AGA GCC-3′;
snf3N383A: 5′-CTA CGG TGT CAA TTT CTT CGC TAA GAC AGG AGT CAG TAA
TAG-3′; rgt2N136A: 5′-GTT AAA ACC TAC ATT GCT CCG GCC CAT TCA TAT TTC
ACC ACT AGC-3′; rgt2N385A: 5′-CTA TGG AGT TAA TTT TTT CGC CAA CAC AGG
GGT GGA CAA C-3′; and sho1N59A: 5′-CCA TCT CAT CTG CAT CCA CCG CTG AAT
CCT TCC CAC GTT TTA CTT GG –3′.
Genetic screen of the YKO gene deletion library
Cells from the YKO gene deletion library were inoculated into a 96-well plate containing
100 μL of SCD liquid medium in each well. After incubation overnight, 100 μL of SCD
liquid medium was added to each culture, and the cells were grown for an additional 24 hr.
Each mutant strain was spotted in duplicate onto agar plates made from SCD medium (2%
agar) with either no salt, 0.5 M KCl, or 1.5 M KCl. 5 μL spots were made using a
multichannel pipette.
After incubating the plates for 24 hr at 30°C, the colonies on each plate were scored for
diminished growth in high salt. After incubating the plates for a minimum of two days, they
were rinsed with deionized water and each colony was scored for penetration into the agar.
Cell-extract preparation and immunoblot analysis
Cells were grown overnight to saturation in SCD medium and re-inoculated into SCD and
grown to A600nm ~1.0. Cells were then treated with 0.5 M KCl for 5 min (unless otherwise
indicated), 1M sorbitol for 5 min, 3 μM α factor pheromone for 30 min, or left untreated at
30°C. Cells were harvested by addition of 100% trichloroacetic acid, centrifugation at 3000
x g for 2 min, washing with 500 μL of 10 mM NaN3 and storage at −80°C. Protein extracts
were prepared by glass bead lysis in trichloroacetic acid as described previously (27).
Protein concentration was determined by DC protein assay, according to the manufacturer’s
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instructions (Bio-Rad Laboratories). Protein extracts were resolved by 10% SDS-PAGE and
immunoblotted with Phospho-p44/42 MAPK antibodies (9101L, Cell Signaling
Technology) at 1:500, Phospho-p38 MAPK antibodies (4631L, Cell Signaling Technology)
at 1:500, Fus3 antibodies (sc-6773, Santa Cruz Biotechnology) at 1:500, Hog1 antibodies
(sc-6815, Santa Cruz Biotechnology), Kss1 antibodies (sc-28547, Santa Cruz
Biotechnology) and glucose-6-phosphate dehydrogenase (G6PDH) antibodies (A9521,
Sigma-Aldrich) at 1:10,000. Immunoreactive species were visualized by chemiluminescent
detection (PerkinElmer Life Sciences LAS) of horseradish peroxidase-conjugated antibodies
(170-5047 and 170-5046, Bio-Rad). Image densitometry was conducted consistently
throughout using NIH ImageJ (28). Statistical analysis was done using GraphPad Prism 4
for at least three independent experiments.
Transcription reporter assay
Pheromone-dependent FUS1-lacZ transcription reporter assays were conducted as described
previously (29). Cells transformed with pRS423-FUS1-lacZ (29) were grown to A600nm
~1.0, then dispensed at 90 μL per well into a 96-well plate and mixed with 10 μL of α-
factor pheromone at the indicated concentrations for 90 min at 30°C. The reaction was
started by adding 20 μL of FDG solution (130 mM PIPES pH 7.2, 0.25% Triton-X100, 0.5
mM fluorescein di-β-galactopyranoside [M0250, Marker Gene Technologies]) for 1 hr at
37°C. The reaction was stopped by adding 20 μL of 1 M sodium bicarbonate. Fluorescence
was quantified using a fluorescence plate reader at 485 μm excitation, 580 μm emission
(SpectraMax M5, Molecular Devices).
Salt-dependent FUS1-lacZ transcription reporter assays were conducted as described above,
except cell cultures at A600nm ~1.0 were dispensed at 65 μL per well and mixed with 35 μL
of KCl at the indicated concentrations for 90 min at 30°C. Each well was then mixed with
20 μL of FDG solution for 3 hr at 37°C. Salt-dependent CRE-lacZ transcription reporter
assays were conducted in the same manner, except using the pRS423-CRE-lacZ reporter
plasmid (30) and treating with FDG for 6 hr. Statistical analysis was done using GraphPad
Prism 4 for at least three independent experiments.
RESULTS
Genome-wide screen reveals a new regulator of osmostress signaling
Under normal circumstances, the HOG pathway is strongly activated by osmotic stress.
Under the same conditions, however, certain yeast mutants incorrectly cross-activate Kss1
and the filamentous growth pathway. Most notably, mutations in the MAPK Hog1, or its
upstream activator Pbs2, grow invasively and penetrate their substratum when exposed to an
osmotic stimulus. When grown on agar plates with salt, these cells cannot be easily rinsed
off the plate (15).
To identify additional regulators of cross-pathway activation, we used the invasive growth
assay to screen the complete YKO yeast gene deletion strain collection (25). The screen did
not reveal any mutants that invaded the agar to the same degree as hog1Δ or pbs2Δ.
Nevertheless, some mutants penetrated the agar in a weak but detectable manner. Upon
retesting, all but one of the mutants grew invasively in the absence of salt and were not
pursued (Supporting Information, Table S1). One remaining mutant, mnn11Δ, was invasive
in the presence but not in the absence of salt and was characterized in detail.
Mnn11 impedes the activation of Kss1 by osmotic stress
We began by reconstructing the mnn11Δ strain and in this case observed no FG behavior,
suggesting that the original YKO strain contained one or more enhancer mutations.
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Substratum penetration is often mediated by activation of the MAPK Kss1. To determine if
the mnn11Δ mutation conferred an elevated MAPK response, we monitored the activity of
Kss1 directly by immunoblotting with an antibody that recognizes the dually-
phosphorylated, fully-activated form of the kinase (phospho-Kss1). Kss1 activity was indeed
elevated in mnn11Δ as compared with wild-type cells, and activation was elevated further
upon stimulation with 0.5 M KCl. Elevated MAPK activity was also evident in the
reconstructed mnn11Δ strain, treated with either 0.5 M KCl or 1 M sorbitol (Figure 2A,
Supporting Information Figure S1). Introduction of MNN11 on a single-copy plasmid
restored normal Kss1 activity (pRS313-MNN11, Figure 2A).
By immunoblotting with an antibody that recognizes Kss1, we determined that mnn11Δ
cells express about 2-fold more Kss1 as compared to wild-type cells (Supporting
Information, Figure S2). This difference in expression is likely due to the 2-fold
transcriptional induction of KSS1 when the FG pathway is activated, for example using an
activated allele of Msb2 (31). Higher Kss1 expression, however, cannot account for the 5-
fold increase in Kss1 phosphorylation in the mnn11Δ strain. Taken together, these results
show that Mnn11 regulates the filamentous growth pathway by limiting the activity of Kss1
under osmotic stress conditions.
Mnn11 selectively regulates Kss1
The findings above reveal that MNN11 is needed to prevent inappropriate activation of Kss1
by osmotic stress. To determine if Mnn11 regulates the functions of any other MAPKs, we
examined the activity of Hog1, Fus3 and Kss1 following stimulation with either salt (KCl)
or the pheromone α-factor. For these experiments we also tested an mnn10Δ mutant strain.
MNN10, like MNN11, encodes an α-1,6-mannosyltransferase present in the lumen of the
Golgi (24). Moreover, Mnn10 and Mnn11 are part of the same macromolecular complex,
and both proteins are required for the extension of mannan chains on N-glycosylated
proteins (24).
Once again we monitored activation of the MAPKs by immunoblotting with antibodies that
recognize the phosphorylated, activated forms of each kinase. As shown in Figure 2B, the
mnn10Δ and mnn11Δ mutants exhibited elevated phospho-Kss1 levels, in both the absence
and presence of salt stimulus. In the stimulated cells, phospho-Kss1 was five- and seven-fold
higher in mnn11Δ and mnn10Δ, respectively, as compared with wild-type cells. This
increase in phospho-Kss1 was well above the two-fold higher expression of total Kss1,
noted above (Supporting Information, Figure S2). In contrast, the mutants had no effect on
the activation of the osmo-sensitive MAPK Hog1. Activation of the mating-specific MAPK
Fus3 was likewise unaffected, although there was a modest elevation in Fus3 abundance.
Thus, Mnn10 and Mnn11 serve to limit salt activation of Kss1 but not of other MAPKs.
We then examined whether Mnn10 or Mnn11 alter the response to α-factor pheromone
(Figure 2B), which normally activates Fus3 and Kss1 but not Hog1. When stimulated with
α-factor, Fus3 activation in the mutants was comparable to wild-type. Here, Kss1 activation
increased about two-fold in mnn10Δ and mnn11Δ cells. This difference mirrors the two-
fold higher expression of Kss1 (Supporting Information, Figure S2). Under no circumstance
was Hog1 activated by pheromone. Hence, these data reveal that Mnn10 and Mnn11 limit
the activation of Kss1 under salt stress conditions. These effects are highly selective, since
the same mutants did not affect activation of Kss1 by pheromone. Moreover, these mutants
did not affect activation of either Fus3 or Hog1 in cells treated with either salt or
pheromone.
Our findings above indicate that Mnn10 and Mnn11 specifically limit activation of Kss1 by
salt. One of the functions of MAPKs is to activate downstream transcription factors that
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induce the expression of a specific set of genes. To corroborate the MAPK activity data, we
monitored gene induction downstream of Kss1. To this end, we used a reporter comprised of
the β-galactosidase gene fused to the FUS1 promoter (FUS1-lacZ). FUS1 is strongly
induced upon activation of either Fus3 or Kss1 (12). Fus3 is not activated by osmotic stress,
however (Figure 2B), so under these conditions FUS1-lacZ induction is mediated solely by
Kss1. As shown in Figure 2C, basal FUS1-lacZ expression was significantly higher in both
mnn10Δ and mnn11Δ mutants, as compared to wild-type cells. This increase is consistent
with the elevated Kss1 activity. However, in no case did we detect a further increase
following treatment with 0.5 M KCl. The absence of any stimulus-dependent change in
transcription-reporter activity contrasts with the marked increase in activation of Kss1 in the
mutant strains. As shown in Figure 2A, Kss1 activation was quite transient, however, and
may not have been sufficient to fully activate the downstream transcription factors. Just as
transient activation of Kss1 is not sufficient to initiate the mating response in wild-type yeast
(32), transient activation of Kss1 did not initiate mating responses in mnn10Δ or mnn11Δ
cells. A second possibility is that, under these specific circumstances, Kss1 activates an
alternative transcription program.
We then monitored FUS1-lacZ as a reporter for the pheromone response pathway mediated
by Fus3 (Figure 2C). Once again the mnn10Δ and mnn11Δ strains exhibited elevated basal
activity, but no further induction with α-factor pheromone, as compared with wild-type
cells. Given that deletion of Mnn11/10 does not influence the activation status of Fus3
(Figure 2B), we would not expect these mutants to significantly alter the FUS1-lacZ
response to pheromone. The pheromone response pathway is mediated primarily by the
MAPK Fus3, and signals through Kss1 only when Fus3 is absent (2). When Fus3 is present,
Kss1 activation is repressed (33). Finally, to examine transcriptional induction downstream
of Hog1, we used a reporter comprised of the β-galactosidase gene fused to the CRE
(cAMP-responsive element) promoter motif (CRE-lacZ) (30). As shown in Figure 2C,
mnn10Δ and mnn11Δ mutants exhibited full induction of CRE-lacZ, although maximum
induction occurred at slightly (<2-fold) lower concentrations of salt as compared to wild-
type cells. Taken together, the transcription-reporter data support the conclusion that Mnn10
and Mnn11 restrict Kss1 activity under basal (unstimulated) conditions. Other unidentified
mechanisms appear to limit transcriptional induction by Kss1 under salt-stimulated
conditions. These mechanisms may account as well for the absence of a reproducible
invasive growth phenotype noted for the mnn11Δ mutant.
Genetic analysis reveals potential targets of Mnn11
MNN11 was shown previously to be required for proper N-glycosylation of proteins. Given
that the absence of MNN11 allows inappropriate activation of Kss1, we reasoned that
deletion of a glycosylated target protein might suppress the observed mnn11Δ phenotype.
To this end we deleted a series of candidate regulators in conjunction with the mnn11Δ
mutation. We then monitored the activation state of Kss1, in the absence or presence of 0.5
M KCl and in the absence or presence of MNN11.
We began our analysis with components of the FG pathway that are shared with the salt-
stress pathway, any of which could limit inappropriate activation of Kss1 by salt; these
include Ste20 (MAPKKKK), Ste11 (MAPKKK), Ste50 (Ste11 adaptor), and Ste7 (MAPKK)
(2). We also tested the pheromone receptor (Ste2) and the G protein β subunit (Ste4) since
they too have the potential to activate Kss1. Of all these pathway components, only Ste2 is
known to undergo N-glycosylation (34).
As shown in Figure 3, Kss1 was no longer activated by salt in the absence of Ste20, Ste50,
Ste11, or Ste7. The mnn11Δste20Δ mutant did exhibit a slight elevation in basal Kss1
activation, presumably due to the presence of kinases related to Ste20 (Cla4 and Skm1). We
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were not able to test this hypothesis because the ste20Δcla4Δ double mutant is inviable
(35). Nevertheless, mnn11Δste20Δ remained unresponsive to salt. In contrast, Kss1 was
still hyperactivated by salt in the ste2Δmnn11Δ and ste4Δmnn11Δ double mutant strains,
even though deletion of STE4 reduces basal signaling and expression of several pheromone
pathway components, both upstream and including Kss1 (2). These data indicate that
components in the FG pathway are needed for Kss1 hyperactivation (Ste20, Ste50, Ste11
and Ste7), whereas components unique to the pheromone response pathway (Ste2 and Ste4)
are not. Taken together, these data suggest that Mnn11 targets a membrane protein other
than Ste2, but one that is upstream of the protein kinases Ste20, Ste11, Ste7 and Kss1.
We next considered candidate targets of Mnn11 in the FG pathway. To this end we tested a
group of cell surface proteins known to act upstream of Kss1 (36); these include Sho1,
Msb2, Opy2 and Hkr1. Sho1 is a transmembrane protein that can form a hetero-oligomeric
complex with the signaling mucin Msb2 (2, 31, 37). Both proteins are likely to be N-
glycosylated and function at the head of both the FG and HOG pathways (2, 31, 36, 38, 39).
Opy2 is an integral membrane protein that interacts with and recruits Ste50 to the plasma
membrane; Opy2 is likewise necessary for both the FG and HOG responses (2, 20, 40).
While it does not have any luminal N-glycosylation sites (N-X-S/T) (41, 42) and therefore
cannot be targeted directly by Mnn11, Opy2 could associate with another glycosylated
binding partner such as Msb2. Finally, Hkr1 is another signaling mucin that functions as an
osmosensor in complex with Sho1 (36).
Once again we constructed double mutant strains lacking Mnn11 and each of the candidate
target proteins. We then exposed these mutant strains to hyperosmotic stress and
immunoblotted for activated Kss1. As shown in Figure 4, Kss1 was hyperactivated by salt in
the hkr1Δmnn11Δ strain. Kss1 activation was also slightly elevated in cells lacking only
Hkr1, consistent with its role as a negative regulator of the FG response (39). In contrast,
Kss1 was no longer activated by salt in the msb2Δmnn11Δ, sho1Δmnn11Δ, or
opy2Δmnn11Δ strains. These data suggest that Mnn11 targets Msb2, Sho1, or Opy2.
However, while these proteins are components of the FG pathway, only Msb2 and Sho1
have consensus N-glycosylation sites. Thus, the effects of Mnn11 on Opy2 are likely to be
indirect.
We then considered proteins that act in conjunction with Opy2, which may in turn be
regulated by Mnn11. It was proposed recently that Opy2 is phosphorylated and regulated by
the casein kinases Yck1 and Yck2 (20). These kinases appear to play a role in pathway
fidelity, since unphosphorylated Opy2 activates Kss1 in preference to Hog1, while
phosphorylated Opy2 activates Hog1 in preference to Kss1 (20). Yck1 and Yck2, in turn, are
thought to be regulated by Snf3 and Rgt2. These proteins are 12-pass transmembrane
glucose sensors responsible for inducing the expression of hexose transporters (20, 43, 44).
Thus, there is an established functional relationship between the two glucose sensors, Opy2,
and pathway fidelity. Indeed, the deletion of both Snf3 and Rgt2 together, but not deletion of
either alone, was able to fully suppress Kss1 hyperactivation in the mnn11Δ background
(Figure 5). In fact, we observed a greater salt-dependent activation of Kss1 in the
snf3Δrgt2Δ strain compared with the mnn11Δsnf3Δrgt2Δ strain. This observation lends
further support to the idea that the glucose sensors Snf3 and Rgt2 might potentially be in the
same pathway with Mnn11, given the diminution of Kss1 activity when Mnn11 is absent.
Analysis of glycosylation site mutants
The data presented above reveal several proteins required to manifest the mnn11Δ
phenotype. Among these are plasma membrane proteins that contain N-glycosylation sites.
These include the glucose sensors Snf3 and Rgt2, as well as the putative osmosensors Msb2
and Sho1. Having shown that these proteins are needed to confer Kss1 hyperactivation in
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salt-treated mnn11Δ cells, we sought to identify specific sites of glycosylation that may be
targeted by Mnn11. For each of the mutant strains we introduced the corresponding gene,
expressed from a single copy plasmid, in which all potential N-glycosylation sites had been
replaced with alanine: Asn-383 in Snf3 (snf3N383A), Asn-136 and Asn-385 in Rgt2
(rgt2N136A+N385A), Asn-59 in Sho1 (sho1N59A), and Asn-30 in Msb2 (msb2N30A). Notably,
aside from Asn-30, Msb2 has six additional potential N-glycosylation sites, which have all
been previously mutated (Msb2-6N/A) without an effect on basal FUS1-lacZ expression
(40). We then exposed these cells to hyperosmotic stress and immunoblotted for activated
Kss1. Of these mutants, only msb2N30A was able to restore Kss1 hyperactivation to the
corresponding deletion strain (msb2Δ) when either expressed from a plasmid (Figure 6A) or
integrated into the genome at the MSB2 locus (Figure 6B). Although we repeatedly and
consistently observed Kss1 hyperactivation following construction of the msb2N30A mutant
strains, the hyperactivation phenotype was less consistent as we propagated the strains,
possibly as a consequence of genetic reversion or the acquisition of suppressor mutations.
Given this instability, we did not attempt to construct any double mutant strains containing
msb2N30A. In contrast, Kss1 responded normally in cells expressing snf3N383A and
rgt2N136A+N385A (snf3Δrgt2Δ strain) or sho1N59A (sho1Δ) (Figure 6). Thus, Msb2, Sho1
and either Snf3 or Rgt2 can limit inappropriate activation of Kss1 by salt. Of these, only
Msb2 requires an intact putative N-glycosylation site to function properly as a pathway
insulator.
DISCUSSION
MAPK pathways often share common signaling components yet exhibit remarkably little
cross-pathway activation. In yeast, salt stress leads to activation of the MAPK Hog1 but not
Fus3, while mating pheromone activates Fus3 but not Hog1. Transient activation of Kss1
has been observed in response to pheromone (32) and osmotic stress (18, 45). However,
neither stimulus is sufficient to invoke the filamentous growth response; this restriction is
due in part to Fus3 phosphorylation of a transcription factor in the invasive pathway, Tec1.
Tec1 is then desumoylated, ubiquitinated, and subsequently degraded (46–50). Another
mechanism entails Hog1 phosphorylation of Ste50, one of several components shared by all
three MAPK pathways. However, the role of Ste50 appears to be limited to cross talk
between the FG pathway and the Sho1 branch of the HOG pathway, since Ste50
phosphorylation-site mutants sustain Kss1 signaling in ssk1Δ cells (18) more so than in
wild-type cells, where both branches of the HOG pathway are functioning (20) (see
Supporting Information, Figure S3). Nevertheless, the realization that Kss1 is activated by
pheromone or osmotic stress, as well as by nutrient deprivation, challenged a long-held
notion that cross-activation would occur only upon loss of Fus3 or Hog1 function. On this
basis we initiated a genome-scale search for additional mutants that disrupt pathway fidelity.
Our approach was modeled after previous efforts to analyze pathway specificity using
comprehensive genomic (31, 45, 51, 52), proteomic (53), and expression profiling strategies
(12, 31, 54, 55). This screen led to the identification of mnn11Δ from the YKO collection,
which could penetrate its substratum in response to hyperosmotic stress. Although we could
not recapitulate the original invasive-growth phenotype in a reconstructed mnn11Δ strain,
we observed an increase in Kss1 phosphorylation, indicative of activation. Based on these
findings we postulate the existence of additional, as yet unidentified, genes that limit
invasive growth in response to Kss1. For example, this could explain why we did not
identify MNN10 in our original screen.
Hence, our effort revealed two new mutants that exhibit inappropriate activation of Kss1;
when MNN10 or MNN11 is absent, Kss1 is hyperphosphorylated in response to salt stress.
In comparison to wild type, the abundance of Kss1 is elevated by two-fold in the deletion
strain (Figure S2). Phospho-Kss1 is likewise elevated but increases an additional 2.5-fold
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under salt-stimulated conditions (Figure 2B). Notably, this salt-dependent increase in
phospho-Kss1 is evident only in the mutant strains. We conclude that Mnn11/10 limit the
overall expression of Kss1 under basal conditions and also limit the activation of Kss1 under
salt stress conditions. The same gene mutations do not alter the response of Kss1 to
pheromone, and they do not alter the response of Fus3 or Hog1 to either pheromone or salt.
MNN10 and MNN11 encode α-1,6-mannosyltransferases associated with the Golgi
apparatus. These enzymes are responsible for extending the mannan chains on all N-
glycosylated proteins destined for the cell surface (24). Deletion of either MNN10 or
MNN11 leads to a reduction in the length of mannan chains on N-glycosylated proteins (24,
56). Based on the known function of Mnn10 and Mnn11, we postulated that one or more N-
glycosylated proteins serve to limit the activity of Kss1 under hyperosmotic conditions and
that the substrate must be glycosylated in order to function properly. We subsequently
established that deletion of a known glycoprotein (Msb2) is sufficient to suppress
hyperactivation of Kss1 in the mnn11Δ mutant. Finally we asked whether loss of a
particular N-glycosylation site would lead to hyperactivation of Kss1, even in the absence of
Mnn11. N-glycosylation-site mutations in Sho1, Snf3, or Rgt2 had no effect on Kss1. In
contrast, mutation of a single candidate N-glycosylation site (Asn-30) in Msb2 led to
inappropriate activation of Kss1, in the manner of mnn11Δ.
Previous studies have indicated that protein glycosylation is important for proper MAPK
signaling, particularly within the FG pathway (40, 57–59). One study reported high basal
activation of Kss1 in cells bearing partial loss-of-function alleles of genes needed for O-
linked and N-linked glycosylation (57). Another study reported FUS1-lacZ induction when a
specific type of O-glycosylation was absent and when the cells were treated with
tunicamycin, a pharmacological inhibitor of protein N-glycosylation. That analysis pointed
to Msb2 as the most likely target for O-glycosylation, and that some combination of O- and
N- glycosylation was needed to maintain signal fidelity (40). Our study advances earlier
findings by identifying a specific mannosyltransferase activity as well a single N-
glycosylation site that is evidently needed for Msb2 to function as a pathway insulator.
While it is well established that Msb2 functions at the head of the FG MAPK pathway (31,
36), a long-standing question is how Msb2 initiates a signaling cascade leading to Kss1. The
MSB2 gene was originally identified as a high-copy suppressor of temperature sensitive
alleles of cdc42 and cdc24 (60). Cdc42 is a Rho family GTPase, while Cdc24 is an exchange
factor that activates Cdc42. Whereas Msb2 associates with Cdc42 (31), Sho1 binds Cdc24
(37). Thus, assembly of Msb2 with Sho1 could bring Cdc42 into close proximity with its
activator (36). Once activated, Cdc42 stimulates a protein kinase cascade beginning with
Ste20 (61, 62) and culminating with Kss1 (31, 36). It is also well established that diminished
nutrient availability leads to filamentous growth in yeast (6–8, 10, 63). Indeed, our data
implicates a new role for the glucose sensors Snf3 and Rgt2 in the filamentous growth
pathway, as these proteins are needed to confer Kss1 hyperactivation in salt-treated cells.
However, it is not established how the pathway can detect changes in nutrient levels, levels
that must fall somewhere between what is needed to support vegetative growth and what
triggers entry into stationary phase (6). One possibility is that a reduction in glucose
availability results in diminished glycosylation of key signaling proteins (64). In this regard,
Msb2 is an attractive target of regulation. Perturbations to the Msb2 extracellular domain
were shown previously to trigger Kss1 activation (31, 37, 40). Our own data reveal a critical
role for a candidate N-glycosylation site in Msb2, Asn-30, as well as for two
mannosyltransferases, Mnn10 and Mnn11, in dictating the activity of Kss1.
While much has been learned, important questions remain. How does protein glycosylation
in general, and Mnn10/11 in particular, regulate Msb2? Synthesis of N-glycans begins in the
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endoplasmic reticulum (ER), where a core oligosaccharide structure is assembled on nascent
proteins during their translocation into the ER lumen (65). These N-glycosylated proteins
are then delivered to the Golgi apparatus, where the oligosaccharide core structure is
elaborated with mannose in one of two ways. Proteins located on endomembranes of the
internal organelles have a small N-linked glycan structure with only a few mannoses added
onto the core oligosaccharide. Proteins that are incorporated into the cell wall and/or plasma
membrane, however, have a large mannan structure that consists of a backbone of about 50
mannose residues with short side branches (56). Mnn10 and Mnn11 are part of the M-pol II
complex in the Golgi. M-pol II is dedicated to extending the mannan chain on all N-
glycosylated proteins, and within this complex both Mnn10 and Mnn11 are thought to be
responsible for cellular α-1,6-mannosyltransferase activity (24). When either of these
enzymes is absent, the consequence is a shorter mannan chain on N-glycosylated proteins
(24, 66).
How might nutrient limitation affect Msb2 glycosylation? Both Mnn10 and Mnn11 use
mannose as a substrate. Mannose is derived from glucose-6-phosphate and glucose. As
glucose become limiting, mannose synthesis will likely be diminished, and this could
prevent Mnn10 and Mnn11 from properly modifying Msb2. Therefore, if under-
glycosylated Msb2 represents the activated form of the protein, the absence of Mnn10 or
Mnn11 could be mimicking the events that occur normally following nutrient deprivation.
The consequence in either case is Kss1 activation. Given the similarity between Msb2 and
the signaling mucin MUC1 in animals, and given that both proteins activate MAP kinases
(reviewed in (67, 68)), the mechanisms reported in yeast could point to similar processes in
humans.
Further studies are needed to determine whether Msb2 is modified by Mnn10 or Mnn11
directly and whether Msb2 has a large mannan structure characteristic of M-pol II
substrates. Addressing this question rigorously would require the reconstitution of M-pol II
components Mnn11, Mnn9, Anp1, Mnn10, and Hoc1 (24), as well as the ability to detect
and quantify the properly modified and mis-modified forms of Msb2. Indeed, our efforts to
monitor Msb2 modifications by immunoblotting were impeded by the poor detection of our
epitope-tagged Msb2, the induction of Msb2 following Kss1 activation, and the existence of
proteolytically-processed forms of the protein in vivo (31, 37).
In summary, we have identified novel mutations that exhibit hyperactivation of Kss1 in
response to osmotic stress stimulation. Our findings indicate that Mnn10 and Mnn11 act
specifically to limit activation of Kss1 by an inappropriate stimulus. We propose that N-
glycosylation of Msb2 in particular is needed for insulation of pathway signaling
components. Together, these findings reveal new proteins and processes needed for proper
MAPK signaling in cells.
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ABBREVIATIONS AND TEXTUAL FOOTNOTES
CRE Cyclic adenosine monophosphate -responsive element
FG filamentous growth
G6PDH glucose-6-phosphate dehydrogenase
HOG high osmolarity glycerol
MAPK mitogen-activated protein kinase
MAPKK mitogen-activated protein kinase kinase
MAPKKK mitogen-activated protein kinase kinase kinase
MAPKKKK mitogen-activated protein kinase kinase kinase kinase
SCD synthetic complete dextrose
YKO yeast knockout
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Figure 1. Components of the HOG, FG and mating pheromone pathways
Some components are omitted for brevity.
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Figure 2. Deletion of MNN11 results in hyperactivation of Kss1 and the filamentous growth
pathway
A) Activation of Kss1 and Hog1; Wild-type, mnn11Δ and pRS313-MNN11-transformed
mnn11Δ cells were stimulated with 0.5 M KCl for the indicated times. Cell lysates were
resolved by 10% SDS-PAGE. Phospho-Kss1 (p-Kss1) and phospho-Hog1 (p-Hog1) were
detected by immunoblotting with phospho-p44/42 and phospho-p38 antibodies, which
recognize the dually phosphorylated and activated forms of Kss1 and Hog1, respectively.
G6PDH served as a loading control. (B) Activation of Kss1, Hog1 and Fus3; WT, mnn10Δ
and mnn11Δ cells were stimulated with 0.5 M KCl for 5 min or with 3 μM α-factor
pheromone for 30 min. Cell lysates were resolved by 10% SDS-PAGE. Specific antibodies
were used to detect the activated form of Hog1, Kss1 and Fus3 (p-Fus3). Total Hog1 and
Fus3 abundance were determined with Hog1 and Fus3 antibodies. G6PDH served as a
loading control. All primary antibodies were recognized by chemiluminescent detection and
quantified by scanning densitometry (ImageJ). The bottom panel shows averaged scanning
densitometry data for three individual experiments. Error bars represent ± SEM. (C)
Transcriptional activation (β-galactosidase activity) was measured spectrofluorometrically
in wild-type (WT), mnn10Δ and mnn11Δ cells transformed with a plasmid containing either
a pheromone-inducible reporter (FUS1-lacZ) or a salt-inducible reporter (CRE-lacZ).
Transcription was induced by the addition of the indicated concentrations of KCl or α-factor
pheromone. Data are the mean ± SE of four individual colonies measured in triplicate and
presented as a percentage of wild-type maximum.
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Figure 3. Mnn11 limits Kss1 activation through the filamentous growth pathway and not the
pheromone response pathway
Activation of Kss1 and Hog1; mnn11Δ and the indicated double gene deletion mutant cells
were stimulated with 0.5 M KCl for 5 min. Cell lysates were resolved by 10% SDS-PAGE
and immunoblotting. Specific antibodies were used to detect the dually phosphorylated,
fully activated forms of Kss1 and Hog1 (p-Kss1 and p-Hog1). G6PDH served as a loading
control. Data are representative of three individual experiments.
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Figure 4. Mnn11 may target the glycoproteins Msb2 or Sho1, or a glycoprotein associated with
Opy2
Activation of Kss1 and Hog1; mnn11Δ and the indicated double mutant cells were
stimulated with 0.5 M KCl for 5 min. Cell lysates were resolved by 10% SDS-PAGE and
immunoblotting. Specific antibodies were used to detect the dually phosphorylated, fully
activated forms of Kss1 and Hog1 (p-Kss1 and p-Hog1). G6PDH served as a loading
control. The panels on the right show quantitation for those conditions that diminished Kss1
activity. The bottom panel is a composite image from a single exposure of a single gel. Error
bars represent ± SEM.
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Figure 5. Both Snf3 and Rgt2 are required to limit the activation of Kss1 by osmotic stress
Activation of Kss1 and Hog1; mnn11Δ and the indicated double or triple mutant cells were
stimulated with 0.5 M KCl for 5 min. Cell lysates were resolved by 10% SDS-PAGE and
immunoblotting. Specific antibodies were used to detect the dually phosphorylated, fully
activated forms of Kss1 and Hog1 (p-Kss1 and p-Hog1). G6PDH served as a loading
control. Data presented are representative of three individual experiments.
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Figure 6. Msb2 Asn-30 is a putative N-glycosylation site required to limit the activation of Kss1
by osmotic stress
(A) Activation of Kss1 and Hog1; mnn11Δ, snf3Δrgt2Δ, sho1Δ, and msb2Δ mutant strains,
transformed with pRS316-SNF3-HA, pRS313-RGT2-HA, pRS315-SHO1-FLAG, pRS316-
MSB2-HA, or the indicated glycosylation-site mutants, were stimulated with 0.5 M KCl for
5 min. Cell lysates were resolved by 10% SDS-PAGE and immunoblotting. Specific
antibodies were used to detect the dually phosphorylated, fully activated forms of Kss1 and
Hog1 (p-Kss1 and p-Hog1). G6PDH served as a loading control. For the relevant
uncomplemented deletion strains, refer to Figures 4 and 5. (B) Activation of Kss1 and Hog1
in wild-type, mnn11Δ or integrated msb2N30A mutant, stimulated with 0.5 M KCl for 5 min
(69).
Lien et al. Page 20
Biochemistry. Author manuscript; available in PMC 2014 January 08.
$w
aterm
ark-text
$w
aterm
ark-text
$w
aterm
ark-text
